2019 Ophthalmology Update
Date: 23/07/2019
Venue: Gordon Eye Surgery, Level 2, 741 Pacific Highway Gordon, NSW, 2073
Provider: The Gordon Eye Surgery
Contact: Donna Glenn, [E] d.glenn@gordoneye.com.au, [P] 294181488
Learning Objectives
- Changes in first line treatment of glaucoma
- Managing patients with glaucoma based on current best practice
- Current studies in myopic progression of children with myopia
- Methods of tracking myopic progression
- Collaborative approaches managing children with progressive myopia
- Current best practice for managing patients with diabetes
- Understanding what changes are in the pipeline for AMD
- Current trials for AMD
- Case Studies from audience to provide more learning opportunities
Max points awarded: 4.00
Session Information
| Name |
|---|
| Paradigm changes in Glaucoma |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.00 |
| Name |
|---|
| What's new in AMD |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.00 |
| Name |
|---|
| Diabetic Eye Disease |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.00 |
| Name |
|---|
| Progressive Myopia in Children |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.00 |
| Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
|---|---|---|---|---|
| Paradigm changes in Glaucoma | Face to Face without Assessment | Yes | No | 1.00 |
| What's new in AMD | Face to Face without Assessment | No | No | 1.00 |
| Diabetic Eye Disease | Face to Face without Assessment | No | No | 1.00 |
| Progressive Myopia in Children | Face to Face without Assessment | Yes | No | 1.00 |